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Abstract
Disrupted neuronal plasticity due to subtle inflammation is considered to play a fundamental role in the pathogenesis of major
depressive disorder. Interferon-α (IFN-α) potentiates immune responses against viral pathogens that induce toll-like receptor-3
(TLR3) activation but evokes severe major depressive disorder in humans by mechanisms that remain insufficiently described.
By using a previously established mouse model of depression induced by combined delivery of IFN-α and
polyinosinic:polycytidylic acid (poly(I:C)), a TLR3 agonist, we provide evidence that IFN-α and poly(I:C) reduce apical
dendritic spine density in the hippocampal CA1 area ex vivo via mechanisms involving decreased TrkB signaling. In vitro,
IFN-α and poly(I:C) treatments required neuronal activity to reduce dendritic spine density and TrkB signaling. The levels of
presynaptic protein vesicular glutamate transporter (VGLUT)-1 and postsynaptic protein postsynaptic density-95 (PSD95) were
specifically decreased, whereas the expression of both synaptic and extrasynaptic α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor 1 (AMPAR1) was increased by IFN-α and poly(I:C) delivery. Patch clamp recordings in
primary hippocampal neurons revealed that morphological changes at the synapse induced by IFN-α and poly(I:C) costimulation
were accompanied by an increased action potential threshold and action potential frequency, indicative of impaired neuronal
excitability. Taken together, IFN-α and poly(I:C) delivery leads to structural and functional alterations at the synapse indicating
that compromised neuroplasticity may play an integral role in the pathogenesis of immune response-induced depression.
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Introduction
Approximately 30 to 50% of patients suffering from chronic
hepatitis C virus (HCV) who are treated with IFN-α develop
severe depression along with confusion states, paranoia, and sui-
cidal ideation [1, 2], which is in many cases a cause of therapy
discontinuation [1, 3]. Nevertheless, the mechanisms of how the
combined action of IFN-α and double-stranded RNA viruses
may induce mood disorders remain poorly understood. Apart
from the inflammatory response induced by any infectious viral
organism, double-stranded RNA viruses induce pronounced
TLR3 activation. We previously showed that IFN-α and TLR3
activation by poly(I:C) regulates the neuronal expression of a
broad set of depression-associated genes in the hippocampus
and prefrontal cortex of mice that were also found to be regulated
in IFN-α-treated depressed patients and which correlated with
depressive behavior in mice [1, 4]. Not surprisingly, we also
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showed that combined delivery of IFN-α and poly(I:C) induced
localized inflammatory responses within the prefrontal cortex
and hippocampus [4].
The regulation of growth, maturation, or pruning of
dendritic spines and synaptic contacts and functional or-
ganization of neuronal networks is essential for the estab-
lishment of physiological behaviors [3, 5]. In fact, re-
duced or increased density of dendritic spines is associat-
ed with depressive behavior in mice lacking efficient syn-
aptic pruning [6]. The glutamatergic system regulates neu-
ronal sprouting, dendritic pruning, and synaptic contact
formation through the regulation of the expression of
brain-derived neurotrophic factor (BDNF) which in turn
activates subcellular signaling pathways through its recep-
tor tropomyosin receptor kinase B (TrkB) [7, 8]. Thus,
compromised neuronal plasticity and communication in
response to neurotransmitter release may contribute to de-
pression pathogenesis.
TLRs, including TLR3, and other components of the
innate immune system are now being recognized to play
a role in neuronal plasticity [9], neuronal growth, and
memory formation [1, 10–12]. IFN-α potentiates immune
responses to double-stranded viruses by activation of the
Janus kinase/signal transduction and activator of
transcription-1 (STAT1) pathway, which amplifies IFN-α
expression and the expression of other genes involved in
growth arrest, cell death, and positive and negative regula-
tors of antiviral responses [3].
Based on these insights, we asked whether IFN-α and
poly(I:C)-induced depression is caused by compromised hippo-
campal plasticity due to alterations to the glutamatergic system.
Using ex vivo studies in the IFN-α and poly(I:C)-induced de-
pression paradigm [4], which we combined with in vitro studies
in primary hippocampal neurons, we characterized structural and
functional correlates of neuronal plasticity changes.
Materials and Methods
Animals
C57BL6/j mice (Harlan, Indianapolis, IN, USA) were
used throughout the study. In ex vivo experiments, male
8–12-week-old mice were used. For in vitro studies, pri-
mary hippocampal cell cultures were obtained from P1–5
pups (morphological studies following enhanced green
fluorescent protein [EGFP] transfection) or E15 embryos
(all other studies). Experiments were performed in accor-
dance with the National Institutes of Health Guidelines for
the Care and Use of Laboratory Animals with local gov-
ernment approval (Bezirksregierung Düsseldorf, TSG966/
08 and TSG1490/15).
Intraventricular IFN-α and Poly(I:C) Delivery
Mice were anesthetized with 1% isoflurane (30% O2, remain-
der N2O) and placed in a stereotactic frame. The skin overly-
ing the skull was opened, the bone cleaned, and a thin cannula
(brain infusion kit 3, Alzet, Cupertino, CA, USA) linked to
mini osmotic pumps (Alzet 1002) filled with (a) 0.1 M
phosphate-buffered saline (PBS; vehicle), (b) mouse IFN-α
(250 IU/day in 0.1 M PBS; Sigma-Aldrich, Deisenhofen,
Germany), (c) poly(I:C) (1 μg/day in 0.1 M PBS;
InvivoGen, San Diego, CA, USA), or (d) IFN-α (as above)
and poly(I:C) (as above) implanted into the left ventricle
0.2 mm anterior and 0.9 mm lateral to bregma, as described
before [4, 13] (n = 10 mice/group, n = 5/ group used for im-
munohistochemistry, and n = 5/group for Golgi-Cox staining
andWestern blotting). The miniosmotic pump was positioned
on the back of the mice. Buprenorphine (0.1 mg/kg; Reckitt
Benckiser, Slough, UK) was intraperitoneally administered as
analgetic. The miniosmotic pump was left in place for 14 days
until sacrifice. For animal sacrifice, mice were anesthetized
with 100 mg/kg ketamine and 16 mg/kg xylazine and
transcardially perfused with 4% paraformaldehyde (PFA) dis-
solved in 0.1 M phosphate-buffered saline (PBS) (for immu-
nohistochemistry) or normal saline (for Golgi-Cox staining
and Western blotting). PFA-fixed brains were postfixed over-
night in 4% PFA and dehydrated overnight in 30% sucrose.
Brains were frozen in dry ice until use. No dropouts due to
pump implantation were noted. No intracerebral bleedings
and no overt infections around the needle tracks were found.
All animals included were employed in the data analysis.
Dendritic Spine Quantification Ex Vivo Using Golgi-
Cox Staining
To quantify dendritic spine densities ex vivo, Golgi-Cox stain-
ing was performed using the FD Rapid GolgiStain™ kit
(PK401A; FD Neurotechnologies, Columbia, MD, USA).
Briefly, mice were anesthetized and decapitated, and brains
were processed following manufacturer’s instructions as be-
fore [14]. Coronal sections of 150μm thickness were prepared
on a cryostat starting at 0.7 mm caudal to bregma. Imaging
was performed using a Zeiss AxioObserver.Z1 Inverted
Microscope under a × 63 objective. Z-stacks of 90–120 μm
thickness at 0.5 μm intervals were prepared. At least 10 ran-
domly selected neurons per mouse were evaluated, of which 2
apical and 2 basal dendrites each were assessed in the CA1
region and dentate gyrus for a total of 5 mice per group.
Results were expressed as dendritic spines/10 μm.
Primary Hippocampal Neuronal Cell Cultures
Brains obtained from E15 embryos or P1–5 pups were dis-
sected on ice cold Hank’s balanced salt solution (HBBS)
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buffer. The meninges were removed, and the brains were cut
through the midline to expose the hippocampi, which were
removed using a fine forceps and incubated in HBSS contain-
ing 0.25% trypsin (15090–046; Gibco, Schwerte, Germany)
and 60 U/mL DNAse-I (D5025; Sigma) for 25 min at 37 °C.
Trypsinization was stopped by addition of 5% fetal bovine
serum (FBS; Invitrogen, Waltham, MA, USA) diluted in
Neurobasal medium. The tissue was mechanically dissociated
by repeated pipetting. Cells were seeded at a density of 7.5 ×
104 cells/mL on coverslips coated with 50 μg/mL poly-
ornithine (P4957; Sigma) and 20 μg/mL laminin-entactin
(Corning, New York, NY, USA). Neurons were incubated in
Neurobasal medium containing 2% B27 (Invitrogen), gluta-
mine (20 mM; Invitrogen), and PenStrep antibiotic mix
(Invitrogen). Half of the medium was refreshed every 4–
5 days. Neurons from P1–5 mice were transfected at 7 days
in vitro (DIV) with a pEGFP-N1 plasmid using an optimized
calcium phosphate precipitation method [15]. All cells were
maintained for 12–14 DIV before initiating experiments. To
study the effects of IFN-α and poly(I:C) on neuronal morphol-
ogy, synapse formation, and depolarization in vitro, IFN-α
(100 IU/mL), poly(I:C) (1 μg/mL), or IFN-α (100 IU/mL)
and poly(I:C) (1 μg/mL) dissolved in Neurobasal medium
were administered over 24 h. A subset of cells were addition-
ally treated with K+ channel blocker 4-aminopyridine (4-AP;
2.5 mM; Tocris Bioscience, Wiesbaden-Nordenstadt,
Germany) [16] for 1 h before protein extraction or fixation
for immunocytochemistry studies.
Immunocytochemistry
Twenty-micrometer thick coronal cryostat sections obtained
from PFA-fixed animals were collected at 100 μm intervals.
Primary neuronal cultures were fixed in 4% PFA in 0.1 M
PBS (for dendritic spine quantification) or methanol (for syn-
apse analyses). Sections or cells were washed, blocked with
5% normal donkey serum (NDS) in 0.1 M PBS-T, and incu-
bated overnight with chicken anti-GFP (1:5000, Abcam),
guinea-pig anti-vesicular glutamate transporter (VGLUT)-1
(1:800; Synaptic Systems, Göttingen, Germany), rabbit anti-
postsynaptic density protein (PSD)-95 (1:800; Cell Signalling,
Danvers, MA, USA), mouse anti-total α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptor-1 (AMPAR1)
(1:800; Synaptic Systems), mouse anti-neurofilament (1:500;
Thermo Fisher, Waltham, MA, USA), rat anti-myelin basic
protein (1:500; Abcam, Cambridge, MA, USA), or rabbit anti-
BDNF (1:400; ab108319, Abcam) antibodies that were de-
tected for 1 h at room temperature with goat anti-chicken
Alexa-488 (1:500; Invitrogen), donkey anti-guinea-pig
Alexa-647 (1:500; Invitrogen), donkey anti-mouse Alexa-
594 (1:500; Invitrogen), donkey anti-rabbit Alexa-488
(1:500; Jackson Immunoresearch), or donkey anti-rat Alexa-
594 antibodies dissolved in 0.1 M PBS-T containing 1%
NDS. Cells were then washed in 0.1 M PBS and mounted
with Prolong Gold medium containing 4′,6-diamidino-2-
phenylindole (DAPI) (Invitrogen). For detection of DNA-
fragmented neurons, neurons were labeled with a terminal
deoxynucleotidyl transferase-mediated fluorescein-dUTP
nick end labeling (TUNEL) kit (In Situ Cell Death
Detection; Roche, Mannheim, Germany) following manufac-
turer’s instructions. In these studies, sections from mice ex-
posed to middle cerebral artery occlusion for 30 min followed
by 24 h reperfusion were stained as positive controls for
TUNEL staining (not shown).
Dendritic Spine Quantification In Vitro by GFP
Immunocytochemistry
Ten-micrometer thick Z-stacks were prepared at 0.1 μm inter-
vals from neurons labeled with anti-GFP antibody using the
same microscope and Apotome correction function as above.
Maximal projections were digitally obtained using Image J.
Images of two primary dendrites per neuron from a total of 45
neurons per treatment were obtained from three independent
experiments. Both for ex vivo and in vitro analyses, a section
of 20–30 μm length of the primary dendrite was analyzed
using the plugin Simple Neurite Tracer from Image J.
Results were expressed as dendritic spines/10 μm.
Synaptic Density Quantification
Synaptic density quantifications were performed as described
previously [17] using our in-house Synapse Counter plugin
for ImageJ (freely available at https://github.com/SynPuCo/
SynapseCounter). Briefly, the structurally complete
glutamatergic synapses were identified by the spatial overlap
of presynaptic marker VGLUT1 and postsynaptic markers
PSD95. For each condition, 56 micrographs were obtained
(n = 4) using the Carl Zeiss LSM 710 confocal microscope
using the alpha Plan-Apochromat × 100 oil objective. The
densities of synaptic puncta were quantified in 66.5 × 66.
5 μm regions containing a single neuron perikaryon.
Western Blots
For protein extraction, hippocampi were quickly dissected,
homogenized, and lysed in 1% NP-40 buffer containing
50 mmol/L Tris-HCl and 150 mmol/L NaCl (pH 7.4) supple-
mented with 5% protease inhibitor cocktail and 1% phospha-
tase inhibitor cocktail-2. Tissues were centrifuged at
13,000 rpm at 4 °C for 15 min. Supernatants were collected
and immediately frozen at − 80 °C until use. Proteins from cell
cultures were extracted using the Trizol (Thermo Fisher)
method following the manufacturer’s instructions and frozen
at − 80 °C until use. Protein concentration was estimated by
the Bradford method (Quick Start Bradford Protein Assay;
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Bio-Rad, Hercules, CA, USA). Ten microgram of samples
(for ex vivo experiments) and 10–50 μg samples (for
in vitro experiments) were loaded on 10% sodium dodecyl
sulfate polyacrylamide gels. After electrophoretic separation,
proteins were transferred to PVDF membranes. Membranes
were blocked with 5% nonfat-dried milk (Sigma-Aldrich) dis-
solved in 0.1 M PBS-T for 1 h at room temperature, washed
and incubated overnight at 4 °C with rabbit anti-VGLUT1
(1:2000; Synaptic Systems), rabbit anti-VGLUT2 (1:1000;
Synaptic Systems), mouse anti-PSD95 (1:1000; Synaptic
Systems), mouse anti-total AMPAR1; 1:1000; Synaptic
Systems), rabbit anti-phospho-Ser831-AMPAR1 (1:1000;
Synaptic Systems), rabbit anti-total TrkB (1:1000; Cell
Signaling), rabbit anti-phospho-TrkB (1:1000; Abcam), rabbit
anti cAMP-response element containing binding protein
(CREB) (1:1000; Millipore, Temecula, CA, USA), mouse
anti-phosphorylated CREB (1:1000; Millipore), mouse anti-
synaptotagmin (1:1000; Synaptic Systems), goat anti-
excitatory amino acid transporter-2 (EAAT2) (1:1000; Santa
Cruz Biotechnology, Dallas, TX, USA), and rabbit anti-
tubulin (1:5000; Synaptic Systems) antibodies. Secondary
peroxidase-coupled goat anti-mouse (1:5000; Santa Cruz,
Dallas, TX, USA) or donkey anti-rabbit (1:5000; Jackson
Immunoresearch, Cambridgeshire, UK) antibodies were incu-
bated for 1 h at room temperature. For calculating phosphor-
ylation ratios, phosphorylated and total forms of proteins were
detected on different membranes and normalized against tu-
bulin levels. Blots were developed using Amersham ECL
Prime Western Blotting Detection Reagent (Life Sciences,
Waltham, MA, USA) and scanned using a digital enhanced
chemiluminescence (ECL) detection device (Thermo Fisher).
Samples from 5 animals per group were analyzed in triplicate.
Patch Clamping
Hippocampal neurons at 12–14 DIV were either stimulat-
ed overnight with IFN-α (100 IU/mL), poly(I:C) (1 μg/
mL), or IFN-α (100 IU/mL) plus poly(I:C) (1 μg/mL).
Prior to recording, culture medium was replaced with an
external solution containing 1.2 mM MgCl2, 10 mM
HEPES, 10 mM glucose, 1.5 mM CaCl2, 2.5 mM KCl,
and 145 mM NaCl (pH 7.4). The pipette solution
contained 140 mM KCl, 1 mM CaCl2·2H2O, 4 mM
MgCl2, 10 mM HEPES, 0.4 mM Na2-GTP, 4 mM Mg-
ATP, and 10 mM EGTA (pH 7.3). Microelectrodes of
1.5 mm thin-walled borosilicate glass (World Precision
Instruments, Friedberg, Germany) were pulled with a
DMZ-Universal Puller (Zeitz-Instruments, Planegg,
Germany) and polished to a final resistance of 3–4 MΩ.
A giga-Ω seal was established between the pipette and
membrane. The resting membrane potential was deter-
mined by injection of zero current after establishing the
whole cell configuration. Current clamp recordings were
acquired in the whole cell configuration using the patch
clamp method. For the experiments, current was injected
to hold neurons at a membrane potential of − 65 mV,
which resembles resting potential of hippocampal neu-
rons. To determine action potential threshold, current
clamp was used, and neurons were stimulated with a step-
per protocol by increasing current steps until action po-
tentials were elicited. Action potential frequency was re-
corded after injecting currents of two-fold the action po-
tential threshold. Voltage clamp recordings were per-
formed in whole cell configuration, and neurons were
clamped at − 65 mV. Data was acquired with an
Axopatch 200B amplifier (Molecular Devices, Biberach,
Germany) with pClamp software 10.6 and analyzed with
Clampfit software 10.6 (Molecular Devices). The signal
was continuously sampled at a frequency of 5 kHz and
filtered at 2.0 kHz.
Statistics
All ex vivo data sets and in vitro data sets from
depolarized neurons or patch clamp studies were ana-
lyzed by one-way analysis of variance (ANOVA) and
Tukey’s post hoc test. For in vitro morphological data
sets, two-way ANOVA with the between group factors
treatment (vehicle, IFN-α, poly (I:C) and IFN-α/
poly(I:C)) and depolarization (Non-depolarized,
depolarized) followed by Tukey’s post hoc test were also
used. p < 0.05 was considered significant.
Results
IFN-α and Poly(I:C) Delivery Reduce Dendritic Spine
Density in the CA1 Region Ex Vivo
To gain insight into neuronal plasticity changes in the
IFN-α- and poly(I:C)-induced depression model, we first
analyzed the dendritic spine density of neurons within the
hippocampal CA1 region and dentate gyrus using Golgi-
Cox stainings ex vivo (Fig. 1a). We observed that IFN-α,
poly(I:C) or combined IFN-α and poly(I:C) delivery sig-
nificantly reduced the density of apical dendritic spines in
the CA1 region (Fig. 1a) [F(3,15) = 4; p = 0.028], but not
of basal dendritic spines in the CA1 region (Fig. 1b) or
dendritic spines in the dentate gyrus (Fig. 1c). The overall
length of dendritic spines was unchanged (Suppl. Fig.
1A–C). Notably, the three treatments influenced dendritic
spine density to a very similar extent (Fig. 1a). We pre-
viously reported that IFN-α and poly(I:C) additively in-
duce depressive symptoms in mice [4]. Western blot anal-
ysis revealed that phosphorylation of the BDNF receptor
TrkB (Fig. 1d) but not the transcription factor CREB (Fig.
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1e), which both mediate neuronal plasticity, was signifi-
cantly reduced by IFN-α poly(I:C) or combined IFN-α
and poly(I:C) delivery [F(3,12) = 3.88; p = 0.038].
Immunohistochemical analyses showed a reduction of
the number of BDNF expressing neurons in the hippo-
campal CA1 region [F(3,27) = 4.73; p = 0.010], but not
DG [F(3,30) = 1.13; p = 0.353] after poly(I:C) exposure,
which was not observed in the combined IFN-α and
poly(I:C) delivery group (Suppl. Fig. 2). We did not find
evidence of neuronal degeneration or demyelination in the
hippocampus (Suppl. Figs. 3 and 4).
IFN-α and Poly(I:C) Differentially Regulate Pre- and
Postsynaptic Proteins of Glutamatergic Synapses Ex
Vivo
Since dendritic spines are sites of major synaptic input, we
next evaluated the abundance of pre- and postsynaptic pro-
teins of glutamatergic synapses by Western blots. Our results
showed that levels of presynaptic protein VGLUT1 were sig-
nificantly reduced by IFN-α or combined IFN-α and
poly(I:C) delivery (Fig. 2a; Suppl. Fig. 5) [F(3,27) = 12.77;
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Fig. 1 Delivery of IFN-α and poly(I:C) reduces apical dendritic spine
density of CA1 neurons and decreases TrkB signaling ex vivo. Spine
density of a CA1 apical dendrites, b CA1 basal dendrites, and c dentate
gyrus dendrites evaluated by Golgi-Cox staining in mice exposed to ve-
hicle, IFN-α (250 IU/day), poly(I:C) (1 μg/day), or combined IFN-α and
poly(I:C). Phosphorylation level of d TrkB and eCREB in the hippocam-
pus of the same mice evaluated by Western blots. For the latter analyses,
Western blots for phosphorylated and total TrkB and CREB were
performed, and expression levels were related to each other. No signifi-
cant differences of CREB phosphorylation were found between groups.
Data are means ± SD, analyzed by one-way ANOVA followed by
Tukey’s post-hoc tests (≥ 10 randomly selected neurons per mouse eval-
uated in A, of which 2 apical and 2 basal dendrites each were examined in
n = 5 mice/ group; tissue samples of n = 5 mice/group separately evaluat-
ed in B as triplicates). **p < 0.01, ***p < 0.001 compared with vehicle-
treated animals. Scale bars = 5 μm.
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but not combined IFN-α and poly(I:C) delivery (Fig. 2b;
Suppl. Fig. 5) [F(3,36) = 9.77; p < 0.001]. The postsynaptic
protein PSD95 was increased by IFN-α or poly(I:C), but not
by combined IFN-α and poly(I:C) delivery (Fig. 2c; Suppl.
Fig. 5) [F(3,36) = 3.60; p = 0.022]. Importantly, the total level
of the postsynaptic protein AMPAR1 was unchanged by
IFN-α and poly(I:C), both when administered alone or in
combinat ion (Fig. 2d; Suppl . Fig. 5D), whereas
Ser831AMPAR1 phosphorylation relative to total AMPAR1
level was significantly reduced by combined IFN-α and
poly(I:C) delivery (Fig. 2e) [F(3,31) = 4.94; p = 0.01].
Phosphorylation of AMPAR1 is a necessary step for the in-
sertion of the AMPAR1 in the postsynaptic membrane that is
required for fast neurotransmission [18]. The presynaptic Ca2+
sensor synaptotagmin-1, which is required for synaptic vesicle
fusion with the presynaptic membrane, and glial glutamate
transporter EAAT2, which removes glutamate from or returns
glutamate to the synaptic cleft, were not altered by IFN-α and
poly(I:C), neither when administered alone nor in combina-




Fig. 2 IFN-α and poly(I:C) differentially regulate pre- and postsynaptic
proteins of glutamatergic synapses ex vivo. Abundance of a presynaptic
glutamatergic proteins VGLUT1 and bVGLUT2, abundance of postsyn-
aptic proteins c PSD95 and d AMPAR1, as well as e phosphorylation
level of AMPAR1 at the Ser831 residue evaluated byWestern blots in the
hippocampus of mice exposed to vehicle, IFN-α (250 IU/day), poly(I:C)
(1 μg/day), or IFN-α and poly(I:C) (as before). Note that VGLUT1 abun-
dance is reduced by IFN-α or combined IFN-α and poly(I:C) delivery.
VGLUT2 is increased by poly(I:C), and PSD95 abundance is increased
by IFN-α or poly(I:C).Whereas total AMPAR1 abundance is unchanged,
Ser831AMPAR1 phosphorylation is reduced by combined IFN-α and
poly(I:C) delivery. Data are means ± SD, analyzed by one-way
ANOVA followed by Tukey’s post hoc tests (tissue samples of n = 5
mice/group evaluated as triplicates). *p < 0.05, **p < 0.001,
***p < 0.001 compared with vehicle
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remain unchanged after prenatal poly(I:C) delivery in the past
[19].
Morphological Effects of IFN-α and Poly(I:C)
Stimulation Are Recapitulated In Vitro
To further evaluate effects of IFN-α or TLR3 activation on
synaptic function, we examined morphological responses of
primary hippocampal neurons exposed to IFN-α and
poly(I:C) at 14 DIV. One significant difference between the
adult hippocampus ex vivo and 14 DIV hippocampal neurons
in vitro is the presence of basal neuronal activity. To address
this issue, we depolarized neurons with 4-AP (2.5 mM) 1 h
before fixation and administered IFN-α and poly(I:C). We
observed a tendency towards a significant main effect for
treatments [F(3,433) = 2.6; p = 0.051], a significant main ef-
fect for depolarization [F(1,433) = 8.98; p = 0.003], and a sig-
nificant interaction between treatments and depolarization
[F(3,433) = 10.4; p < 0.001]. Post hoc analysis showed that
IFN-α delivery significantly increased the density of dendritic
spines under non-depolarized conditions, while poly(I:C) and
combined IFN-α and poly(I:C) delivery had no effect
(Fig. 3a). Depolarization significantly increased the density
of dendritic spines in vehicle-treated cells compared with
non-depolarized vehicle conditions (Fig. 3a). In response to
depolarization, IFN-α and poly(I:C), both when applied alone
and in combination, significantly reduced the density of den-
dritic spines (Fig. 3a). Again, all three treatments influenced
dendritic spine density to a very similar extent. Hence, the
morphological responses of depolarized neurons resembled
the effects seen ex vivo. Western blots revealed that, under
depolarized conditions, TrkB phosphorylation was signifi-
cantly reduced by IFN-α, whereas TrkB phosphorylation fol-
lowing poly(I:C) and combined IFN-α and poly(I:C) delivery
did not differ from the depolarized vehicle conditions (Fig. 3b)
[F(3,14) = 3.56; p = 0.042]. We did not observe any effect of
IFN-α and poly(I:C) on CREB phosphorylation, neither when
applied alone or in combination (Fig. 3c). Hence, the under-
lying mechanisms of action are apparently similar ex vivo and
in vitro, indicating a role of BDNF signaling that occurs in a
neuronal activity-dependent manner.
IFN-α and Poly(I:C) Dysregulate Glutamatergic
Synapses In Vitro
To determine whether glutamatergic synapses were also
disrupted in vitro, we examined the expression of the presyn-
aptic protein VGLUT1 and the postsynaptic proteins PSD95
and AMPAR1 in hippocampal primary neurons depolarized
by 4-AP by immunocytochemistry. Here, we observed a re-
duction of the number of VGLUT1 (Fig. 4a) [F(3,112) = 8.74;
p = 0.001] and PSD95 (Fig. 4b) [F(3,108) = 2.68; p < 0.001]
puncta by poly(I:C) and combined IFN-α and poly(I:C)
delivery. Consequently, the number of glutamatergic synapses
as defined by VGLUT1/PSD95 colocalization was reduced
(Fig. 4c) [F(3,106) = 6.08; p = 0.001]. In contrast, we ob-
served that AMPAR1 expression associated to VGLUT1/
PSD95 synapses (e.g., synaptic AMPAR1) showed a compen-
satory increase induced by poly(I:C) and combined IFN-α and
poly(I:C) delivery [F(3,112) = 90.07; p < 0.001] (Fig. 4d).
Extrasynaptic AMPAR1 expression also showed a compen-
satory increase induced by poly(I:C) that was partly attenuated
by IFN-α (Fig. 4e) [F(3,112) = 70.91; p < 0.001]. This is in
contrast to ex vivo measurements where we observed no
change of AMPAR1 levels. These data suggest that
AMPAR1 trafficking may also be compromised in vitro by
inflammatory conditions. The reduction of PSD95 and conse-
quent increase of synaptic and extrasynaptic AMPAR1 sug-
gest a dissociation of AMPAR1 and PSD95 that could impair
AMPAR1 efficacy and neuronal excitability. AMPAR1 phos-
phorylation was tendentially reduced by poly(I:C) but not
combined IFN-α and poly(I:C) delivery (Suppl. Fig. 7)
[F(3,11) = 2.38; p = 0.145].
IFN-α and Poly(I:C) Decrease Neuronal Excitability
In Vitro
Finally, we asked whether neuronal excitability would be al-
tered by IFN-α or poly(I:C) in 14 DIV neurons. Patch clamp
recordings revealed that IFN-α increased the action potential
threshold. However, this effect was only statistically signifi-
cant when IFN-α was used in combination with poly(I:C)
(Fig. 5a) [F(3,21) = 3.71; p = 0.027]. IFN-α and poly(I:C)
did not induce significant changes to average voltage (Fig.
5b), time to peak (Fig. 5c), and rise time (Fig. 5d) of the action
potential when applied alone or in combination. We observed
that the frequency of action potentials was significantly in-
creased by poly(I:C) although this effect was partially antag-
onized by costimulation with IFN-α (Fig. 5e) [F(3,18) = 3.96;
p = 0.025]. Since action potential threshold and frequency are
dependent on Na+ channels [20], we conclude that these re-
sults suggest that IFN-α and poly(I:C) impair neuronal excit-
ability by reducing Na+ channel functionality.
Discussion
By combining ex vivo and in vitro studies, we report here
morphological, biochemical, and electrophysiological corre-
lates of reduced dendritic and synaptic plasticity in the CA1
region of the hippocampus and dentate gyrus in a model of
IFN-α and TLR3 activation-induced depression in mice
which we previously characterized on the behavioral level
[4]. While previous studies evaluated the effect of IFN-α or
poly(I:C) on behavior and inflammation when administered
alone, we stringently characterized the independent and
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combined effects of both stimuli on several aspects of hippo-
campal neuronal plasticity. Stimulation with IFN-α and
poly(I:C) reduced CA1 apical dendritic spine density in asso-
ciation with reduced VGLUT1 levels and TrkB phosphoryla-
tion and reduced BDNF expression in the hippocampal CA1
region ex vivo. Notably, while AMPAR1 and PSD95 levels
were stable, Ser831AMPAR1 phosphorylation was mildly re-
duced ex vivo but not in vitro by combined IFN-α and
poly(I:C) delivery. Decreased dendritic spine density and re-
duced levels of VGLUT1 were observed in vitro only after
neuronal depolarization was induced by 4-AP. Remarkably,
PSD95 was reduced, and AMPAR1 was increased in vitro
under neuronal depolarization conditions. This indicates that
the presynaptic compartment (e.g., VGLUT1) is particularly
sensitive to IFN-α or poly(I:C) stimulation, therefore suggest-
ing that presynaptic mechanisms of glutamate release may
play a primary role during the early stages of immune-
induced depression as compared with the postsynaptic com-
partment. The observed differences between ex vivo and
in vitro conditions may be explained by the absence of glial
and microglial inflammatory responses in vitro that we pre-
viously characterized ex vivo [4]. Patch clamp studies
a b
c
Fig. 3 Delivery of IFN-α and poly(I:C) reduces dendritic spine density of
primary hippocampal neurons and decreases TrkB signaling in vitro in a
neuronal activity-dependent way. a Dendritic spine density of primary
hippocampal neurons that were either non-depolarized or had been
depolarized by 4-AP (2.5 mM) at 14 days in vitro (DIV) and had been
exposed to vehicle, IFN-α (100 IU/mL), poly(I:C) (1 μg/mL), or IFN-α
and poly(I:C) (as before). Neuronal depolarization with 4-AP increased
dendritic spine density compared with non-depolarized vehicle condi-
tions. IFN-α and poly(I:C) reduced dendritic spine density in depolarized,
but not in non-depolarized cells both when administered alone and in
combination with each other. Abundance of b TrkB phosphorylation
and c CREB phosphorylation in depolarized primary hippocampal
neurons (2.5 mM 4-AP) exposed to vehicle conditions, IFN-α 100 (IU/
mL), poly(I:C) (1 μg/mL), or IFN-α and poly(I:C) (as before) at 14 DIV
evaluated by Western blots. TrkB phosphorylation was significantly re-
duced by IFN-α, whereas CREB phosphorylation was not influenced by
IFN-α and poly(I:C). Data are mean ± SD, analyzed by one-way
ANOVA followed by Tukey’s post hoc tests (n = 3 experiments with ≥
15 randomly selected neurons per experiment evaluated in A, of which 2
dendrites each were examined; n = 3 experiments evaluated in B as trip-
licates). *p < 0.05, ***p < 0.001 compared with non-depolarized vehicle,
##p < 0.01, ###p < 0.001 compared with depolarized vehicle. Scale bar =
5 μm
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revealed that IFN-α increased the action potential threshold
of primary hippocampal neurons, while poly(I:C) increased
the frequency of action potentials. Hence, our studies suggest
that disruption of glutamatergic synapses by IFN-α and
poly(I:C) leads to insufficient neurotrophic support through
BDNF-TrkB signaling, resulting in reduced dendritic spine
density and impaired electrophysiological activity as hall-
marks of depression (Suppl. Fig. 8).
The delivery of inflammatory cytokines and immune stimu-
lants is widely used to study depression pathogenesis [21].
Previous studies already suggested that inflammation may neg-
atively influence BDNF signaling, thus limiting neuronal plas-
ticity in the hippocampus, prefrontal cortex, amygdala, and
raphe nuclei and causing the emergence of depressive-like be-
havior [21] although behavioral, structural, molecular, and elec-
trophysiological data remain poorly integrated. IFN-α was
shown to decrease BDNF synthesis and primary hippocampal
neuronal branching in vitro by mechanisms involving NMDA
receptor signaling [22] and to reduce hippocampal
neurogenesis and cause fatigue and immobility in tail suspen-
sion and forced swim tests in mice [23]. Poly(I:C) has been
reported to decrease cortical neuron branching by promoting
cytokine release from monocytes in vivo [10, 12], reduce pre-
and postsynaptic protein content, interfere with memory forma-
tion, reduce neuronal excitability, and render the brain more
susceptible to stress during adulthood [24, 25]. Patients suffer-
ing from IFN-α therapy-related depression show negative reg-
ulation of vast signaling pathways relevant for neuronal plas-
ticity including extracellular axonal guiding molecules and sub-
cellular signaling deficiencies related to cytoskeleton dynamics
and neuronal morphology (e.g., ephrins and rho GTPases) [26].
Our data expands previous results by comparing the individual
effects of IFN-α and poly(I:C) to the combined condition.
Although we did not evaluate behavioral correlates of depres-
sion in the present study, we demonstrated in an earlier study
[4] that combined IFN-α and poly(I:C) were necessary to in-
duce significant depression-like symptoms. In the present
study, both IFN-α and poly(I:C) reduced dendritic and synaptic
plasticity when administered alone, yet with diverse actions on
different glutamatergic markers that were sometimes antagonis-
tic. For example, IFN-α reversed the upregulation of VGLUT2
by poly(I:C) ex vivo, attenuated the upregulation of AMPAR1
by poly(I:C) in vitro, and attenuated the increase of action po-




Fig. 4 Loss of glutamatergic synapses upon IFN-α and poly(I:C) treat-
ment in vitro. Glutamatergic synapses were evaluated after exposure of
primary hippocampal neurons to vehicle, IFN-α (100 IU/mL), poly(I:C)
(1 μg/mL), or IFN-α and poly(I:C) (as before) at 14 DIV, followed by 1 h
4-AP-induced (2.5 mM) neuronal depolarization for 1 h. Abundance of a
VGLUT1 and b PSD95 was reduced by poly(I:C) and combined IFN-α
and poly(I:C) delivery causing an overall significant reduction of c glu-
tamatergic VGLUT1/PSD95 synapses. d Intrasynaptic and e
extrasynaptic AMPAR1 expression analysis showed a compensatory in-
crease induced by poly(I:C) that was counteracted by IFN-α in the com-
bined stimulation condition. Representative images of analyzed synapses
are shown in f (DAPI counterstaining in blue). Data are mean ± SD,
analyzed by one-way ANOVA followed by Tukey’s post hoc tests (n =
4 independent experiments with a total of 56 cells/group). *p < 0.05,
**p < 0.01, ***p < 0.001 compared with vehicle/#p < 0.05 compared
with poly(I:C). Scale bar = 5 μm
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both IFN-α and poly(I:C) reduce dendritic and synaptic plas-
ticity and that reduced plasticity may predispose to the devel-
opment of depression-like symptoms when signaling processes
in the pre- and postsynaptic membranes are simultaneously
modified. This may explain the additive influence of both stim-
uli on the manifestation of depression-like symptoms [4]. Of
note, IFN-α and poly(I:C) are sometimes delivered intraperito-
neally over longer periods or at higher doses to achieve
depressive-like behaviors [27]. Apparently, intraventricular de-
livery results in accelerated molecular, structural, and behavior-
al responses.
Glutamatergic transmission has been proposed as a key
part of the etiology of mood disorders [8]. IFN-α-treated
HCV patients showed increased ratios of glutamine to gluta-
mate in the cerebral cortex (indicative of low cortical gluta-
mate), which positively correlated with depression and anxi-
ety [28]. It was recently observed that glutamatergic activation
of the infralimbic cortex by glutamate transporter-1 blockade
or AMPA microinfusion reduced depression-like behavior by
promoting serotonin release from the raphe nuclei in rats [29],
which may partly explain how serotonin reuptake inhibitors
reduce IFN-α-mediated depression [30]. Importantly, another
study found a correlation of VGLUT1 downregulation in the
cerebral cortex and depression in postmortem human samples
[31]. Inflammatory processes therefore may influence the
emergence of depression not only by inhibiting physiological
neuronal sprouting or synaptic pruning but also by limiting
glutamate availability within the synapse. Indeed, IL-1,
TNF-α, IFN-γ, and poly(I:C) inhibit astrocytic glutamate up-
take by deactivating the glutamate transporter EAAT1, thus
modulating NMDA spontaneous currents in hippocampal
slices [32–34]. Our data further adds that VGLUT1 is reduced
by either IFN-α or poly(I:C), thus probably reducing gluta-
mate availability within the synaptic cleft given that VGLUT1
elimination reduces the synaptic vesicle pool and also de-
creases neuronal excitability [35]. Importantly, acute IFN-α
stimulation of hippocampal slices reduced miniature excitato-
ry postsynaptic excitatory currents [36], which is consistent
with a reduction of presynaptic glutamate release as indicated
by our analyses of VGLUT1 expression.
Given the fact that glutamate release regulates BDNF synthe-
sis and TrkB activation through CREB phosphorylation [7], a
reduction of glutamate release as a consequence of reduced
VGLUT1 may provide a stringent explanation for reduced
TrkB signaling in our study. Interestingly, type I IFNs and
TLR3 activation can independently modulate the expression of
BDNF and TrkB. IFN-β reduced neuronal differentiation of pri-
mary cortical cells through downregulation of BDNF and TrkB
via a JAK/STAT-1-dependent mechanism [37]. Intraperitoneal
administration of poly(I:C) caused a very fast reduction of BDNF
and TrkB mRNA in the frontal cortex and hippocampus [38].
Depression scores were negatively associated with serum BDNF
levels in IFN-α−treated HCV patients [39]. TrkB signaling and





Fig. 5 IFN-α and poly(I:C) impair neuronal excitability. Neuronal
excitability was evaluated by patch clamp recording of neurons
incubated overnight with vehicle, IFN-α (100 IU/mL), poly(I:C) (1 μg/
mL), or IFN-α and poly(I:C) (as before). IFN-α induced a significant
increase in a action potential threshold only in the presence of
poly(I:C). No alterations were observed for b average voltage, c time to
peak, or d rise time of the action potential. Poly(I:C) significantly in-
creased the action potential frequency, and IFN-α partially reverted this
effect when combined with poly(I:C). Data are mean ± SEM, analyzed by
one-way ANOVA, followed by Tukey’s post hoc tests (n = 5–8 neurons/
group). *p < 0.05 compared to vehicle
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models ofmood disorders [7], which is in linewith our finding of
reduced neuronal excitability in response to IFN-α and poly(I:C)
exposure. Future studies should further characterize local plastic-
ity responses in defined subcellular compartments (e.g., synap-
tosomes). In early stages of depression pathogenesis, such studies
may help to identify promising therapeutic targets for new anti-
depressant drugs, via which the compromised neuroplasticity
may be restored.
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